FEATURED EDITORIAL
EQUULUS Cofounder and CEO Robert Discordia discusses his company’s pursuit of an analog ibogaine as a potential therapy for CNS disorders.
- A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine
- AI Is Unearthing New Drug Candidates, But It Still Needs Human Oversight
- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
- AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance
- AI Technologies Drive Drug Development And Enhance Patient Experience In Neurology & Rare Diseases
- 2024 LIMS Trends
- Drugging The Undruggable: Strategies And Future Directions
FEATURED APPLICATION CONTENT
-
Learn about a more human-relevant platform that enables researchers to assess the trafficking and killing efficiency of immunotherapy as well as the proof-of-concept of immuno-oncology co-therapy.
-
This study aimed to identify the optimal cell culture conditions to yield high cell density and maintain high cell viability with consistent aggregate morphology and pluripotency marker expression.
-
Discover a first-of-its-kind human LF-Chip containing B, T, plasma and antigen-presenting cells to test functional immunization responses to vaccines and adjuvants in vitro.
-
A Bone Marrow-Chip (BM-Chip) was created to recapitulate relevant hematopoietic cell types in a three-dimensional (3D), mechanically active next-generation in vitro model.
-
Learn how Organ-Chips are being used to rapidly identify promising treatments, investigate virus evolution, and analyze how mechanical forces influence the innate immune response to viral infections.
-
This study examines the expansion, functionality, and phenotype of CAR-T cells cultured in the CellGenix® GMP T cell culture medium (TCM) compared to other commercially available T cell media.
-
This study demonstrates the automated magnetic isolation of CD4/CD8+ cells from fresh or frozen leukapheresis using a functionally closed cell processing system paired with a modular application.
-
Explore key process operations, some of the challenges in manufacturing high-concentration biologics, and factors to consider for process optimization.
-
Discover how an Organ-Chip can be used to create a comprehensive recapitulation of the proximal tubule, addressing the need for more human-relevant preclinical models in the pharmaceutical industry.
-
Discover an Intestine-Chip that integrates the robust cell sourcing of organoids with Organs-on-Chips technology to overcome experimental limitations and yield a closer-to-human transcriptomic profile.
-
There is a growing need for more human-relevant preclinical models. Explore how Organ-Chips offer a viable solution and can be used to create a comprehensive recapitulation of the liver sinusoid.
FEATURED NEWS HEADLINES
- BigHat Biosciences Enters Into Strategic Collaboration To Leverage Machine Learning In Antibody Discovery & Design
- AI Designs New Drugs Based On Protein Structures
- Drug Targeting Clear Cell Renal Cell Carcinoma Shows Promising Approach
- Xaira Therapeutics Launches To Deliver Transformative Medicines By Advancing And Harnessing AI For Drug Discovery And Development
- OncoC4 Announces FDA Clearance Of IND Application For Novel SIGLEC 10 Immune Checkpoint Inhibitor ONC-841 For Solid Tumors
- Tharimmune Announces Option Agreement For Key Technologies For Generating HER2/HER3 Antibody Drug Conjugates (ADCs)
- Medicure Receives US FDA Fast Track Designation For MC-1 For PNPO Deficiency
- FDA Approves Immunotherapy Drug Combo For Non-Muscle Invasive Bladder Cancer After UCLA-Led Research Shows Improved Outcomes For Patients
- Takeda, Astellas And Sumitomo Mitsui Banking Announce Master Agreement To Establish Joint Venture Company For Incubation Of Early Drug Discovery Programs
- New Copper-Catalyzed C-H Activation Strategy From Scripps Research
ARCHIVED NEWSLETTER
- 04.23.24 -- Novel Approaches In Chromatography Process Development
- 04.23.24 -- Drugging The Undruggable: Strategies And Future Directions
- 04.16.24 -- 8 Key Takeaways Of The Proposed FDA Modernization Act 3.0
- 04.15.24 -- Successfully Navigate The Path To IND Submission
- 04.11.24 -- The Business of Biotech: Leaders in ADC Technologies